EyePoint completes enrollment of LUGANO and LUCIA trials

Published on July 31, 2025
EyePoint Pharmaceuticals completes enrollment for the LUCIA trial, advancing DURAVYU's potential as a new treatment for wet AMD.
Continue reading on website
Other news

Stanton Optical integrates new dry eye therapy, retinal imaging technologies to care arsenal in 35 locations

July 31, 2025
The expanded clinical suite at Stanton Optical will include keratography, optical coherence tomography, and personalized therapy options for patients with dry eye.

The Neural Network: Exploring The Role of Neuromodulation in Dry Eye Disease Management

July 31, 2025
In this podcast, Marjan Farid, MD; Beeran Meghpara, MD; and John Hovanesian, MD; review the role of neuromodulation in the pathogenesis of dry eye disease (DED). Additionally, the expert panel discusses a case study of a typical patient presenting with DED and reviews current and newly available treatment options.